Anthem, Inc. (NYSE:ANTM) Shares Purchased by FineMark National Bank & Trust

FineMark National Bank & Trust raised its holdings in shares of Anthem, Inc. (NYSE:ANTMGet Rating) by 0.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,986 shares of the company’s stock after buying an additional 156 shares during the period. FineMark National Bank & Trust’s holdings in Anthem were worth $15,754,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Baillie Gifford & Co. raised its stake in shares of Anthem by 14.7% during the fourth quarter. Baillie Gifford & Co. now owns 4,582,312 shares of the company’s stock valued at $2,124,085,000 after purchasing an additional 587,649 shares during the period. Geode Capital Management LLC increased its stake in shares of Anthem by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 4,174,578 shares of the company’s stock worth $1,929,914,000 after buying an additional 51,641 shares during the last quarter. Sanders Capital LLC increased its stake in shares of Anthem by 9.1% in the third quarter. Sanders Capital LLC now owns 3,977,162 shares of the company’s stock worth $1,640,909,000 after buying an additional 330,942 shares during the last quarter. Invesco Ltd. increased its stake in shares of Anthem by 29.4% in the third quarter. Invesco Ltd. now owns 2,955,310 shares of the company’s stock worth $1,101,739,000 after buying an additional 671,275 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in shares of Anthem by 0.6% in the fourth quarter. Nordea Investment Management AB now owns 2,117,892 shares of the company’s stock worth $989,013,000 after buying an additional 13,144 shares during the last quarter. Institutional investors own 84.28% of the company’s stock.

A number of equities analysts have commented on ANTM shares. UBS Group lifted their price objective on shares of Anthem from $477.00 to $541.00 and gave the stock a “buy” rating in a report on Tuesday, March 29th. Cowen boosted their price target on shares of Anthem from $472.00 to $642.00 in a report on Thursday, April 21st. Argus boosted their price target on shares of Anthem from $475.00 to $500.00 and gave the company a “buy” rating in a report on Monday, February 7th. Mizuho boosted their price target on shares of Anthem from $510.00 to $545.00 in a report on Wednesday, May 4th. Finally, Cowen boosted their price target on shares of Anthem from $472.00 to $642.00 in a report on Thursday, April 21st. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $545.23.

In other news, EVP Peter D. Haytaian sold 17,703 shares of the stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $460.71, for a total transaction of $8,155,949.13. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Ramiro G. Peru sold 990 shares of the stock in a transaction on Thursday, May 19th. The stock was sold at an average price of $468.88, for a total value of $464,191.20. Following the sale, the director now owns 9,405 shares in the company, valued at approximately $4,409,816.40. The disclosure for this sale can be found here. Insiders sold 21,116 shares of company stock valued at $9,743,637 over the last 90 days. 0.28% of the stock is currently owned by corporate insiders.

Anthem stock traded up $12.93 during trading hours on Friday, reaching $492.85. 1,365,038 shares of the company were exchanged, compared to its average volume of 1,080,061. The firm has a market cap of $118.82 billion, a price-to-earnings ratio of 19.40, a PEG ratio of 1.35 and a beta of 0.97. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.55. The stock has a 50-day moving average of $496.31 and a 200 day moving average of $461.12. Anthem, Inc. has a 12 month low of $355.43 and a 12 month high of $533.68.

Anthem (NYSE:ANTMGet Rating) last issued its quarterly earnings results on Wednesday, April 20th. The company reported $8.25 EPS for the quarter, topping analysts’ consensus estimates of $7.81 by $0.44. Anthem had a return on equity of 18.71% and a net margin of 4.33%. The company had revenue of $38.10 billion during the quarter, compared to analyst estimates of $37.28 billion. During the same period in the previous year, the company earned $7.01 earnings per share. The company’s quarterly revenue was up 17.6% compared to the same quarter last year. As a group, research analysts forecast that Anthem, Inc. will post 28.55 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 24th. Investors of record on Friday, June 10th will be paid a $1.28 dividend. This represents a $5.12 dividend on an annualized basis and a dividend yield of 1.04%. This is a positive change from Anthem’s previous quarterly dividend of $1.13. The ex-dividend date of this dividend is Thursday, June 9th. Anthem’s dividend payout ratio is presently 20.16%.

Anthem Company Profile (Get Rating)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Further Reading

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.